CDH2 and cancer: Nonetheless, CHC, a classical MCT inhibitor with more affinity for MCT1 [48], led to enhanced SIRT1 expression, decreased histone acetylation, and N-cadherin expression, associating with reduced cell migration in cancer and normal kidney cell lines.